Elisabeth Puchhammer-Stöckl to Humans
This is a "connection" page, showing publications Elisabeth Puchhammer-Stöckl has written about Humans.
Connection Strength
0.080
-
Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria. J Clin Virol. 2021 04; 137:104795.
Score: 0.007
-
Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19. Genet Med. 2021 05; 23(5):963-967.
Score: 0.007
-
Human recombinant soluble ACE2 in severe COVID-19. Lancet Respir Med. 2020 11; 8(11):1154-1158.
Score: 0.007
-
Association of Severe Influenza Virus Infections With CD226 (DNAM-1) Variants. J Infect Dis. 2019 08 30; 220(7):1162-1165.
Score: 0.007
-
Torque Teno Virus as a Novel Biomarker Targeting the Efficacy of Immunosuppression After Lung Transplantation. J Infect Dis. 2018 11 05; 218(12):1922-1928.
Score: 0.006
-
Temporal dynamics of the lung and plasma viromes in lung transplant recipients. PLoS One. 2018; 13(7):e0200428.
Score: 0.006
-
NKG2C Deletion Is a Risk Factor for Human Cytomegalovirus Viremia and Disease After Lung Transplantation. J Infect Dis. 2018 02 14; 217(5):802-806.
Score: 0.006
-
Human cytomegalovirus (HCMV) genotype populations in immunocompetent individuals during primary HCMV infection. J Clin Virol. 2010 Jun; 48(2):100-3.
Score: 0.004
-
Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes. Allergy. 2022 01; 77(1):230-242.
Score: 0.002
-
RT-PCR based SARS-CoV-2 variant screening assays require careful quality control. J Clin Virol. 2021 Aug; 141:104905.
Score: 0.002
-
The versatility of external quality assessment for the surveillance of laboratory and in vitro diagnostic performance: SARS-CoV-2 viral genome detection in Austria. Clin Chem Lab Med. 2021 09 27; 59(10):1735-1744.
Score: 0.002
-
Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown. Sci Rep. 2021 05 12; 11(1):10158.
Score: 0.002
-
Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays. J Clin Microbiol. 2021 04 20; 59(5).
Score: 0.002
-
SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses. Sci Immunol. 2021 03 04; 6(57).
Score: 0.002
-
Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR. Clin Chem Lab Med. 2021 04 27; 59(5):987-994.
Score: 0.002
-
Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Sci Transl Med. 2020 12 09; 12(573).
Score: 0.002
-
Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs. Infection. 2021 Feb; 49(1):171-175.
Score: 0.002
-
Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests. J Infect Dis. 2020 07 06; 222(3):362-366.
Score: 0.002
-
First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences. J Clin Virol. 2020 08; 129:104537.
Score: 0.002
-
Successful management of the first reported case in Austria of COVID-19 with ARDS. Infection. 2020 Aug; 48(4):647-651.
Score: 0.002
-
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe. BMC Infect Dis. 2018 06 01; 18(1):251.
Score: 0.002
-
Torquetenovirus Dynamics and Immune Marker Properties in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective Longitudinal Study. Biol Blood Marrow Transplant. 2018 01; 24(1):194-199.
Score: 0.001
-
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe. Clin Infect Dis. 2016 Mar 01; 62(5):655-663.
Score: 0.001
-
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infect Dis. 2014 Jul 21; 14:407.
Score: 0.001
-
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. J Acquir Immune Defic Syndr. 2006 Mar; 41(3):352-60.
Score: 0.001
-
Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection. Br J Haematol. 1992 Feb; 80(2):160-5.
Score: 0.000